Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors - Trial NCT06399432

Timeline & Enrollment

Primary Outcome

Percentage of participants who had a change in blood monocytes profiles.,Percentage of participants who had a change in T-cell profiles.,Change in blood monocyte profile.,Change in T-cell profiles.

Summary

In this study, participants will have 3 or 4 total study visits over approximately 10 total
 weeks. There is a two week medication washout period in between the 1st and 2nd visits. This
 washout only applies if participants are using a prohibited psoriasis medication (such as
 topical steroids or oral psoriasis medications, like methotrexate). During the washout
 period, participants will have to stop the prohibited medication(s). If participants are not
 using any prohibited medications, then the 1st and 2nd visits can be combined and
 participants will only have 3 total in-person visits. Participants will be randomly assigned
 (by chance; like flipping a coin) to either the Mediterranean Diet or no dietary
 intervention. After 4 weeks on the diet, participants will start treatment with either
 Anti-IL-17 or Anti-IL-23 therapy. The biologic treatments will prescribed by the participants
 regular dermatologist and not as a part of the study.

ICD-10 Classifications